Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06367283
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-03
Brief Title:
Metformin Treatment of Patients With Hand Osteoarthritis
Sponsor:
Marius Henriksen
Organization:
Frederiksberg University Hospital
Study Overview
Official Title:
Metformin Treatment of Patients With Hand Osteoarthritis A Randomised Placebo-controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
METRO
Brief Summary:
To compare metformin 2 g daily or maximum tolerated dose for 16 weeks with placebo as a treatment of hand osteoarthritis symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None